Skånskt samarbete ska hitta nya substanser mot folksjukdomar

Lundabolagen Saromics Biostructures och Red Glead Discovery startar läkemedelsprojekt som riktar sig mot epigenetiska dysfunktioner.

Beactica och Medivir i samarbete

Ska leta efter nya leadsubstanser inom hemligt terapiområde.

Fat cells' reaction differs with body weight

The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...

Creative antibiotics rensar i portföljen

Avbryter utvecklingssamarbete med norska Qotics.

Medicult needs a word of advice

Medicult Board retains advisers, regarding the previous offer from Vitrolife.

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Discovery of new role for leukemia gene

Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...

Infidelity produces faster sperms

Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

Metabolic pro heads prefect post

The dean of the Department of Biomedicine at the Sahlgrenska Academy has appointed a new assistant prefect.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Bioläkemedel är här för att stanna

Småmolekyler fortsätter att dominera men chansen för ett bioläkemedel att nå ända fram är dubbelt så stort som för kemiska läkemedel.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Pfizer lays a chunky bid on Wyeth

that may lead to lay-offs of some 8,000 persons.

How to be a perfect mingler

Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...

Mingling do's and don'ts

Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...

Sales Representative, Applied Biosystems

International models among science parks

Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...